Sumitomo Pharma Co., Ltd. (DNPUF)
14.36
-2.38
(-14.19%)
USD |
OTCM |
Dec 12, 16:00
Sumitomo Pharma EPS Diluted (Quarterly): 1.496 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0253 |
| Nxera Pharma Co., Ltd. | -0.1253 |
| PeptiDream Inc. | -0.0575 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.0331 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 594.38M |
| Revenue (Quarterly) | 807.75M |
| Total Expenses (Quarterly) | 213.37M |
| Enterprise Value | 7.224B |
| Gross Profit Margin (Quarterly) | 61.73% |
| Profit Margin (Quarterly) | 73.58% |
| Earnings Yield | 18.20% |
| Operating Earnings Yield | 7.82% |
| Normalized Earnings Yield | 18.20 |